HealthEquity (HQY) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for HealthEquity (HQY) stock.

Latest Upgrades and Downgrades for HealthEquity Stock

Date	Firm	Analyst	Action	Rating Change	Price Target
—	BMO Capital	Sean Dodge	PT Raise	Outperform	$105→$125
—	Barclays	Peter Warendorf	PT Raise	Overweight	$110→$115
—	Deutsche Bank	George Hill	PT Raise	Buy	$135→$142
—	BTIG	David Larsen	Maintained	Buy	$115
—	BTIG	David Larsen	PT Raise	Buy	$110→$115
—	RBC Capital	Ryan Halsted	Maintained	Outperform	$108
—	Citizens	Constantine Davides	PT Raise	Market Outperform	$110→$111
—	RBC Capital	Ryan Halsted	PT Raise	Outperform	$100→$108
—	Barrington Research	Alexander Paris	Maintained	Outperform	$110
—	BMO Capital	Sean Dodge	Upgrade	Market Perform→Outperform	$85→$105
—	Deutsche Bank	George Hill	PT Raise	Buy	$120→$128
—	Barrington Research	Alexander Paris	PT Cut	Outperform	$125→$110
—	JP Morgan	Alexei Gogolev	PT Cut	Overweight	$129→$123
—	RBC Capital	Daniel R. Perlin	PT Cut	Outperform	$110→$100
—	Barclays	Glen Santangelo	PT Cut	Overweight	$118→$110
—	BTIG	David Larsen	PT Cut	Buy	$130→$110
—	Goldman Sachs	David Roman	Downgrade	Neutral→Sell	$89
—	Keybanc	Scott Schoenhaus	PT Raise	Overweight	$120→$125
—	Barclays	Glen Santangelo	Initiate	Overweight	$118
—	Barrington Research	Alexander Paris	Maintained	Outperform	$125

Analyst Ratings News

PRO
BMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125

BMO Capital analyst Sean Dodge maintains HealthEquity (NASDAQ:HQY) with a Outperform and raises the price target from $105 to $125.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on HealthEquity, Raises Price Target to $115

Barclays analyst Peter Warendorf maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $110 to $115.

Benzinga Newsdesk

PRO
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $142

Deutsche Bank analyst George Hill maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $135 to $142.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on HealthEquity, Maintains $115 Price Target

BTIG analyst David Larsen reiterates HealthEquity (NASDAQ:HQY) with a Buy and maintains $115 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on HealthEquity, Raises Price Target to $115

BTIG analyst David Larsen maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $110 to $115.

Benzinga Newsdesk

PRO
RBC Capital Reiterates Outperform on HealthEquity, Maintains $108 Price Target

RBC Capital analyst Ryan Halsted reiterates HealthEquity (NASDAQ:HQY) with a Outperform and maintains $108 price target.

Benzinga Newsdesk

HealthEquity Inc

HealthEquity (HQY) Stock Price Target 2026

Latest Upgrades and Downgrades for HealthEquity Stock

HealthEquity (HQY) Stock Price Target 2026

Latest Upgrades and Downgrades for HealthEquity Stock

Analyst Ratings News

PROBMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125

PROBarclays Maintains Overweight on HealthEquity, Raises Price Target to $115

PRODeutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $142

PROBTIG Reiterates Buy on HealthEquity, Maintains $115 Price Target

PROBTIG Maintains Buy on HealthEquity, Raises Price Target to $115

PRORBC Capital Reiterates Outperform on HealthEquity, Maintains $108 Price Target

Analyst Ratings News

PROBMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125

PROBarclays Maintains Overweight on HealthEquity, Raises Price Target to $115

PRODeutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $142

PROBTIG Reiterates Buy on HealthEquity, Maintains $115 Price Target

PROBTIG Maintains Buy on HealthEquity, Raises Price Target to $115

PRORBC Capital Reiterates Outperform on HealthEquity, Maintains $108 Price Target

PRO
BMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125

PRO
Barclays Maintains Overweight on HealthEquity, Raises Price Target to $115

PRO
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $142

PRO
BTIG Reiterates Buy on HealthEquity, Maintains $115 Price Target

PRO
BTIG Maintains Buy on HealthEquity, Raises Price Target to $115

PRO
RBC Capital Reiterates Outperform on HealthEquity, Maintains $108 Price Target

PRO
BMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125

PRO
Barclays Maintains Overweight on HealthEquity, Raises Price Target to $115

PRO
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $142

PRO
BTIG Reiterates Buy on HealthEquity, Maintains $115 Price Target

PRO
BTIG Maintains Buy on HealthEquity, Raises Price Target to $115

PRO
RBC Capital Reiterates Outperform on HealthEquity, Maintains $108 Price Target